Healthcare provider profile · identity verified

Uzma Imran, M.D

Internal Medicine · TAYLOR, MI · NPI 1215376488

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	657	191
Amlodipine Besylate	Amlodipine Besylate	580	166
Losartan Potassium	Losartan Potassium	475	126
Levothyroxine Sodium	Levothyroxine Sodium	455	110
Simvastatin	Simvastatin	420	120
Lisinopril	Lisinopril	409	113
Omeprazole	Omeprazole	327	100
Hydrochlorothiazide	Hydrochlorothiazide	312	92
Gabapentin	Gabapentin	243	73
Metformin Hcl	Metformin Hcl	229	63
Metoprolol Succinate	Metoprolol Succinate	222	68
Metoprolol Tartrate	Metoprolol Tartrate	193	63
Famotidine	Famotidine	170	58
Sertraline Hcl	Sertraline Hcl	161	49
Metformin Hcl Er	Metformin Hcl	157	51
Furosemide	Furosemide	144	48
Pantoprazole Sodium	Pantoprazole Sodium	138	48
Pravastatin Sodium	Pravastatin Sodium	136	36
Eliquis	Apixaban	132	38
Albuterol Sulfate Hfa	Albuterol Sulfate	127	59
Fluticasone Propionate	Fluticasone Propionate	127	49
Tamsulosin Hcl	Tamsulosin Hcl	127	43
Trazodone Hcl	Trazodone Hcl	122	36
Potassium Chloride	Potassium Chloride	112	36
Nifedipine Er	Nifedipine	102	30
Rosuvastatin Calcium	Rosuvastatin Calcium	98	30
Buspirone Hcl	Buspirone Hcl	93	32
Glipizide Er	Glipizide	89	27
Spironolactone	Spironolactone	88	30
Atenolol	Atenolol	87	24
Jardiance	Empagliflozin	80	25
Glipizide	Glipizide	77	25
Hydralazine Hcl	Hydralazine Hcl	77	29
Ozempic	Semaglutide	72	26
Alendronate Sodium	Alendronate Sodium	70	19
Ezetimibe	Ezetimibe	69	20
Escitalopram Oxalate	Escitalopram Oxalate	67	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	67	24
Montelukast Sodium	Montelukast Sodium	65	18
Donepezil Hcl	Donepezil Hcl	61	16
Allopurinol	Allopurinol	60	15
Baclofen	Baclofen	59	20
Carvedilol	Carvedilol	57	15
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	56	17
Felodipine Er	Felodipine	54	15
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	11
Warfarin Sodium	Warfarin Sodium	52	20
Triamcinolone Acetonide	Triamcinolone Acetonide	47	29
Ventolin Hfa	Albuterol Sulfate	46	25
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	45	45
Citalopram Hbr	Citalopram Hydrobromide	45	11
Clopidogrel	Clopidogrel Bisulfate	44	18
Methocarbamol	Methocarbamol	41	25
Xarelto	Rivaroxaban	40	11
Lovastatin	Lovastatin	39	suppressed
Paroxetine Hcl	Paroxetine Hcl	38	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	36	24
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	35	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	34	15
Memantine Hcl	Memantine Hcl	33	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	33	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	33	suppressed
Duloxetine Hcl	Duloxetine Hcl	32	11
Farxiga	Dapagliflozin Propanediol	32	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Myrbetriq	Mirabegron	31	suppressed
Klor-Con M20	Potassium Chloride	30	suppressed
Meclizine Hcl	Meclizine Hcl	30	15
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Hydrocortisone	Hydrocortisone	28	20
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	11
Midodrine Hcl	Midodrine Hcl	27	suppressed
Topiramate	Topiramate	27	suppressed
Diclofenac Sodium	Diclofenac Sodium	26	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	18
Torsemide	Torsemide	24	suppressed
Trulicity	Dulaglutide	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Cephalexin	Cephalexin	23	19
Tiotropium Bromide	Tiotropium Bromide	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	22
Fenofibrate	Fenofibrate	22	suppressed
Ibuprofen	Ibuprofen	22	14
Meloxicam	Meloxicam	21	12
Chlorthalidone	Chlorthalidone	20	suppressed
Lamotrigine	Lamotrigine	20	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Tizanidine Hcl	Tizanidine Hcl	20	11
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Incruse Ellipta	Umeclidinium Bromide	18	suppressed
Colchicine	Colchicine	17	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Mirabegron Er	Mirabegron	17	suppressed
Primidone	Primidone	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Amoxicillin	Amoxicillin	15	14
Gemfibrozil	Gemfibrozil	15	suppressed
Nystatin	Nystatin	15	13
Tolterodine Tartrate	Tolterodine Tartrate	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Bupropion Xl	Bupropion Hcl	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Lidocaine	Lidocaine	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	12
Prednisone	Prednisone	14	12
Risperidone	Risperidone	14	suppressed
Breo Ellipta	Fluticasone/Vilanterol	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Januvia	Sitagliptin Phosphate	13	suppressed
Ramipril	Ramipril	13	suppressed
Tramadol Hcl	Tramadol Hcl	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	12	suppressed
Lactulose	Lactulose	12	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	12	suppressed
Ammonium Lactate	Ammonium Lactate	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Benzonatate	Benzonatate	11	suppressed
Bupropion Hcl	Bupropion Hcl	11	suppressed
Humalog Kwikpen U-100	Insulin Lispro	11	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Spiriva Respimat	Tiotropium Bromide	11	suppressed
Tradjenta	Linagliptin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error